Back

Targeting myeloperoxidase in inflammatory atherosclerosis

European Heart Journal

4 September 2018
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes IMAGING Cardiac Magnetic Resonance (CMR)

Abstract

Abstract

Contributors

Max L Senders
Max L Senders

Author

Willem J M Mulder
Willem J M Mulder

Author

You may be interested in
thumbnail
Congress Presentation
Myeloperoxidase inhibition reverses the inflammatory proteomic pattern in heart failure with preserved ejection fraction
1 July 2021
thumbnail
Congress Session
Atherosclerosis: molecular mechanisms and therapeutic targets
29 August 2026
thumbnail
Congress Presentation
Myeloperoxidase as a biomarker for anticipating STEMI in individuals with atrial fibrillation.
13 May 2024
thumbnail
Congress Presentation
Design of a phase 2b randomized clinical trial (ENDEAVOR) to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in HF with preserved and mildly reduced EF
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources